Furthermore, IRF8 is transcriptionally repressed in many acute and chronic myeloid leukemia (AML and CML, respectively) patients [15, 16], suggesting a link between IRF8 activity and these diseases. This evidence concerns the gene IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive.